Development & Aid, Environment, Headlines, Health, North America

HEALTH: Big Promise, Small Prospects Seen in Genetic Technologies

Stephen Leahy

TORONTO, Canada, Jun 24 2002 (IPS) - Genetic research could help save millions of lives in poor countries by helping defeat diseases like malaria, tuberculosis, and HIV/AIDS, says the World Health Organisation (WHO). Some experts say faith in the genomic industry — with its emphasis on high technology and profits — is misplaced.

Genomic research could “allow developing countries to leapfrog decades of medical development,” says Gro Harlem Brundtland, the agency’s director general. If handled correctly, it has the potential to bring citizens in developing countries “greatly improved care and modern methods in the much more immediate future”.

A team of 14 internationally prominent doctors, medical researchers and ethicists in rich and poor countries has put together a 241-page WHO report, “Genomics and World Health”.

“Genomics and related technologies should be used to narrow the existing unethical inequities in global health. The report is an important first step towards this goal,” says Dan Brock of Brown University in the United States, one of the authors.

Some 99 percent of genomic research is not directed at cures for diseases of the South. Rather, “it’s about making money,” says Nancy Olivieri, a professor of paediatrics and head of the sickle cell anaemia research programme at the Toronto Hospital for Sick Children.

Moreover, Olivieri questions the efficacy of investing enormous amounts of money in this high-tech research that may never yield results when those monies could be put to good use with improvements in conventional treatments or better distribution of existing medicines right now.

Genomic research involves large-scale creation and use of databases through a high level of automation, and therefore requires major capital investment, the WHO report acknowledges. In the South, only Brazil, China, India and Cuba have made the necessary investment in equipment and highly specialised personnel.

To improve on this, the report calls for the formation of a Global Health Research Fund, a new central research and development (R&D) organisation with an initial 1.5 billion dollars in funding. It says a second 1.5 billion dollars should be made available to institutions that are working on developing new vaccines and drugs for HIV/AIDS, tuberculosis and malaria.

DNA research is under way with some projects already yielding results. These include:

– Creating a new designer mosquito that cannot carry the malaria parasite.

– Clinical trials for two new types of vaccines, derived from genetic research, against tuberculosis.

– Clinical trials in Nairobi, Kenya and Oxford, Britain of a DNA-based AIDS vaccine candidate designed specifically for Africa.

In addition, scientists are using DNA technology to produce vaccines that can be incorporated into potatoes, other vegetables and fruits, against hepatitis B, cholera, measles, and human papilloma virus.

“There are considerable risks with this new technology,” says Debra Harry, a member of the Paiute Nation in the United States and director of the Indigenous Peoples’ Council on Biocolonialism. “Genetically modified organisms are alive and we can’t predict with certainty what they will do, especially over the long term.”

Harry also objects to the taking of DNA from native peoples and from the remains of their ancestors. “Indigenous people are still being exploited by the gene hunters who take samples of their genes and tell them they are helping cure their diseases,” she says.

Genes are not involved in many of the health issues natives people face, such as Type II diabetes.

“The gene hunters say they’re looking for the smoking gene in the Maori in New Zealand or the binge-drinking gene in southwest Asia. It’s hogwash to think that genes are responsible for behaviours that are the result of 500 years of colonialism and loss of hope for a future,” says Harry.

“The new priesthood of molecular biology thinks the process of life is nothing while the genes of life have immense value,” Harry says. “What about the sacred relationship indigenous peoples have with the natural world?”

In her view, genomics is the largest ethical problem science has ever had to face and there is no social framework or policy around which to consider the impacts and risks involved.

The WHO report examines some ethical issues such as the desirability of establishing large databases of human DNA information and the question of who should have control and how access should be granted. Another ethical problem deals with decisions families may make regarding children as a result of DNA research.

“These concerns are based on the notion that in our attempts to help families or individuals with a genetic disease, we may increase the number of deleterious genes in the human gene pool,” the report says. “Preventing parents who are carrying the same genetic defect from reproducing, and hence having affected children, will tend to interfere with the normal evolutionary mechanism for reducing the frequency of deleterious genes within a population.”

 
Republish | | Print |

Related Tags